Angiogenesis in cancer, vascular, rheumatoid and other disease
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Self-citationThalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Research works printed but not linked: 9
- Holmgren, L., O'Reilly, M. & Folkman, J. in press (1994).
- Kohn, E. et al. Phase I trial of signal transduction inhibitor, CAI. Proc. Amer. Assoc. Cancer Res. 35,244(1994).
- Folkman, J. Clinical applications of angiogenesis research. New Engl. J. Med. in press (1994).
- Watanabe, H., Nguyen, M., Schizer, M., Li, V., Hayes, D.R., Sallan, S., Folkman, J. Basic fibroblast growth factor in human serum – a prognostic test for breast cancer. Molec. Biol. Cell 3, 324a (1992).
- Szabo, S. et al. Orally administered FGF mutein: Effect on healing of chronic duodenal ulcers in rats. Digestive Disease and Sciences 34, 1323 (1989).
- Hull, M.A., Cullen, D.J.E. & Hawkey, C.J. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106, A97 (1994).
- Wolfe, M.M. et al. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: A preliminary report. Gastroenterology 106, A212 (1994).
- Brem, H., Goto, F., Budson, A., Saunders, L. & Folkman, J. Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV, 674–677 (1994).
- O'Reilly, M.S. et al. (unpublished data).
Cited by
Items 501–600 of 1,046
Waltenberger, J., Lange, J., & Kranz, A. (2000) · Circulation · doi:10.1161/01.cir.102.2.185 · Cited by 252
El‐Kenawi, A. E., & El‐Remessy, A. B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12344 · Cited by 253
Maier, J. A. M., Malpuech-Brugère, C., Zimowska, W., Rayssiguier, Y., & Mazur, A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.01.002 · Cited by 242
Molecular mechanisms of anti-angiogenic effect of curcumin
Gururaj, A. E., Belakavadi, M., Venkatesh, D. A., Marmé, D., & Salimath, B. P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02306-9 · Cited by 253
MATHEMATICAL MODELING OF TUMOR-INDUCED ANGIOGENESIS
Chaplain, M. A. J., McDougall, S. R., & Anderson, A. R. A. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095807 · Cited by 255
Salvén, P., Orpana, A., & Joensuu, H. (1999) · PubMed · Cited by 252
Proinflammatory functions of vascular endothelial growth factor in alloimmunity
Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17712 · Cited by 251
Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, R. W., & Folkman, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1558 · Cited by 253
Self-citationKyzas, P. A., Cunha, I. W., & Ioannidis, J. P. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1870 · Cited by 252
Gille, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.4.750 · Cited by 251
Gerber, H., Kowalski, J., Sherman, D. A., Eberhard, D. A., & Ferrara, N. (2000) · PubMed · Cited by 251
New perspectives in clinical oncology from angiogenesis research
Folkman, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00423-6 · Cited by 250
Self-citationEnhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2002) · Nature Biotechnology · doi:10.1038/nbt0302-264 · Cited by 252
Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P., & Kreutzer, D. L. (1998) · Urology · doi:10.1016/s0090-4295(97)00491-3 · Cited by 251
Li, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
Rajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1096-7 · Cited by 252
Jung, Y. D., Mansfield, P. F., Akagi, M., Takeda, A., Liu, W., Bucana, C. D., Hicklin, D. J., & Ellis, L. M. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00013-8 · Cited by 249
Metastatic tumours to the oral region. An overview
Hirshberg, A., & Buchner, A. (1995) · European Journal of Cancer Part B: Oral Oncology · doi:10.1016/0964-1955(95)00031-3 · Cited by 252
Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices
Davis, G. E., Bayless, K. J., & Mavila, A. (2002) · The Anatomical Record · doi:10.1002/ar.10159 · Cited by 253
Antiangiogenic properties of natural polyphenols from red wine and green tea
Oak, M.-H., El Bedoui, J., & Schini-Kerth, V. B. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.09.004 · Cited by 248
Lane, H. A., Wood, J. M., McSheehy, P. M. J., Allegrini, P. R., Boulay, A., Brueggen, J., Littlewood-Evans, A., Maira, S.-M., Martiny-Baron, G., Schnell, C. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2057 · Cited by 249
Salven, P., Teerenhovi, L., & Joensuu, H. (1997) · Blood · doi:10.1182/blood.v90.8.3167 · Cited by 249
Iron Oxide-Based Nanostructures for MRI and Magnetic Hyperthermia
Hilger, I., & Kaiser, W. A. (2012) · Nanomedicine · doi:10.2217/nnm.12.112 · Cited by 243
Prognostic molecular markers in early breast cancer
Esteva, F. J., & Hortobagyi, G. N. (2004) · Breast Cancer Research · doi:10.1186/bcr777 · Cited by 247
Hennequin, L. F., Thomas, A. P., Johnstone, C., Stokes, E. S. E., Plé, P. A., Lohmann, J.-J. M., Ogilvie, D. J., Dukes, M., Wedge, S. R., Curwen, J. O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990345w · Cited by 241
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
VEGF Signaling Through NADPH Oxidase-Derived ROS
Ushio–Fukai, M. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1556 · Cited by 245
Vincent, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24586 · Cited by 242
Itakura, J., Ishiwata, T., Shen, B., Kornmann, M., & Korc, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<27::aid-ijc5>3.0.co;2-8 · Cited by 234
Sagar, S. M., Yance, D., & Wong, R. K. (2006) · Current Oncology · doi:10.3747/co.v13i1.77 · Cited by 243
Integrin Targeted Delivery of Chemotherapeutics
Chen, K., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0189 · Cited by 242
Tanimoto, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg132 · Cited by 239
Beerepoot, L. V., Mehra, N., Vermaat, J. S. P., Zonnenberg, B. A., Gebbink, M. F. G. B., & Voest, E. E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh017 · Cited by 244
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C., Stratton-Thomas, J. R., Shuman, M. A., & Rosenberg, S. (1996) · PubMed · Cited by 242
The role of social and psychologic resources in caregiving of cancer patients
Nijboer, C., Tempelaar, R., Triemstra, M., van den Bos, G. A. M., & Sanderman, R. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<1029::aid-cncr1094>3.0.co;2-1 · Cited by 239
Stoeltzing, O., McCarty, M. F., Wey, J. S., Fan, F., Liu, W., Belcheva, A., Bucana, C. D., Semenza, G. L., & Ellis, L. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh168 · Cited by 241
Saishin, Y., Saishin, Y., Takahashi, K., Silva, R. L. E., Hylton, D., Rudge, J. S., Wiegand, S. J., & Campochiaro, P. A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10246 · Cited by 239
Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., & Lu, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6367 · Cited by 239
Klagsbrun, M., & Moses, M. A. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80081-7 · Cited by 237
Arcondeguy, T., Lacazette, E., Millevoi, S., Prats, H., & Touriol, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt539 · Cited by 235
Muller, Y. A., Christinger, H. W., Keyt, B. A., & de Vos, A. M. (1997) · Structure · doi:10.1016/s0969-2126(97)00284-0 · Cited by 237
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Mihaly, J., Prager, G., & Binder, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-11-0669 · Cited by 236
THE LYMPHATIC VASCULATURE: Recent Progress and Paradigms
Oliver, G., & Alitalo, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.012704.132338 · Cited by 237
Formation of New Vasa Vasorum in Vasculitis
Kaiser, M., Younge, B., Björnsson, J., Goronzy, J. J., & Weyand, C. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65175-9 · Cited by 233
The basement membrane matrix in malignancy
Engbring, J. A., & Kleinman, H. K. (2003) · The Journal of Pathology · doi:10.1002/path.1396 · Cited by 237
Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease
Mofidi, R., Crotty, T. B., McCarthy, P., Sheehan, S. J., Mehigan, D., & Keaveny, T. V. (2001) · Journal of British Surgery · doi:10.1046/j.0007-1323.2001.01823.x · Cited by 235
Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., & Olson, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00399-3 · Cited by 236
Davidson, D. J., Haskell, C., Majest, S., Kherzai, A., Egan, D. A., Walter, K. A., Schneider, A., Gubbins, E. F., Solomon, L., Chen, Z., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3426 · Cited by 235
Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes
Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/714037693 · Cited by 234
Li, B., Lalani, A. S., Harding, T. C., Luan, B., Koprivnikar, K., Huan Tu, G., Prell, R., VanRoey, M. J., Simmons, A. D., & Jooss, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1558 · Cited by 232
Bloch, B. N., Furman-Haran, E., Helbich, T. H., Lenkinski, R. E., Degani, H., Kratzik, C., Susani, M., Haitel, A., Jaromi, S., Ngo, L., et al. (2007) · Radiology · doi:10.1148/radiol.2451061502 · Cited by 234
George, M. L., Eccles, S. A., Tutton, M. G., Abulafi, A. M., & Swift, R. I. (2000) · PubMed · Cited by 233
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Salven, P., Orpana, A., Teerenhovi, L., & Joensuu, H. (2000) · Blood · doi:10.1182/blood.v96.12.3712 · Cited by 234
Angiogenesis and breast cancer metastasis
Ellis, L., & Fidler, I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92774-3 · Cited by 232
Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F., & Jain, R. K. (1996) · Europe PMC (PubMed Central) · Cited by 232
SDF-1 Activity on Microvascular Endothelial Cells
Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., Vannier, J.-P., Soria, J., Vasse, M., & Soria, C. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00292-9 · Cited by 232
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., & Majima, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00496-5 · Cited by 233
Ginkgo biloba extracts and cancer: a research area in its infancy
DeFeudis, F. V., Papadopoulos, V., & Drieu, K. (2003) · Fundamental & Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00156.x · Cited by 234
Predicting the survival of patients with breast carcinoma using tumor size
Michaelson, J. S., Silverstein, M., Wyatt, J., Weber, G., Moore, R., Halpern, E., Kopans, D. B., & Hughes, K. (2002) · Cancer · doi:10.1002/cncr.10742 · Cited by 232
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis, P. D., Dougherty, G. J., Blakey, D. C., Galbraith, S. M., Tozer, G. M., Holder, A. L., Naylor, M. A., Nolan, J., Stratford, M. R. L., Chaplin, D. J., et al. (2002) · PubMed · Cited by 231
Improved Viability of Random Pattern Skin Flaps through the Use of Adipose-Derived Stem Cells
Lu, F., Mizuno, H., Uysal, C. A., Cai, X., Ogawa, R., & Hyakusoku, H. (2008) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000293876.10700.b8 · Cited by 231
Ruohola, J. K., Valve, E. M., Karkkainen, M. J., Joukov, V., Alitalo, K., & Härkönen, P. L. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00003-9 · Cited by 230
Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin
Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, K. A., Hopfer, H., Chandamuri, B. R., Kharbanda, S., & Kalluri, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007764200 · Cited by 230
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
Hermann, C., Assmus, B., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.402 · Cited by 228
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γActivation
Jacob, A., Wu, R., Zhou, M., & Wang, P. (2007) · PPAR Research · doi:10.1155/2007/89369 · Cited by 228
Human endometrial angiogenesis
Gargett, C. E., & Rogers, P. A. (2001) · Reproduction · doi:10.1530/rep.0.1210181 · Cited by 226
Endogenous angiogenesis inhibitors and their therapeutic implications
Cao, Y. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00023-1 · Cited by 228
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Aicher, A., Rentsch, M., Sasaki, K.-I., Ellwart, J. W., Fändrich, F., Siebert, R., Cooke, J. P., Dimmeler, S., & Heeschen, C. (2007) · Circulation Research · doi:10.1161/01.res.0000259562.63718.35 · Cited by 228
Fibroblast growth factors are required for efficient tumor angiogenesis.
Compagni, A., Wilgenbus, P., Impagnatiello, M.-A., Cotten, M. L., & Christofori, G. (2000) · PubMed · Cited by 258
Resveratrol and quercetin inhibit angiogenesis in vitro
Igura, K., Ohta, T., Kuroda, Y., & Kaji, K. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00443-8 · Cited by 229
Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
Mukhopadhyay, S., Barnés, C. M., Haskel, A., Short, S. M., Barnes, K. R., & Lippard, S. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc070031k · Cited by 226
Radiolabelled RGD peptides for imaging and therapy
Gaertner, F. C., Kessler, H., Wester, H.-J., Schwaiger, M., & Beer, A. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2028-1 · Cited by 227
He, Y., Smith, S. K., Day, K. A., Clark, D. E., Licence, D. R., & Jones, D. S. (1999) · Molecular Endocrinology · doi:10.1210/me.13.4.537 · Cited by 226
The role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 228
Heine, V. M., Zareno, J., Maslam, S., Joëls, M., & Lucassen, P. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03951.x · Cited by 225
Shabo, I., Stål, O., Olsson, H., Doré, S., & Svanvik, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23527 · Cited by 225
Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids
Luo, H., Jiang, B.-H., King, S. M., & Chen, Y. C. (2008) · Nutrition and Cancer · doi:10.1080/01635580802100851 · Cited by 224
Regulation of tumor angiogenesis by thrombospondin-1
Ren, B., Yee, K. O., Lawler, J., & Khosravi-Far, R. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.11.002 · Cited by 225
Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies
Scappaticci, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.033 · Cited by 225
IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue
Simonini, A., Moscucci, M., Muller, D. W. M., Bates, E. R., Pagani, F. D., Burdick, M. D., & Strieter, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1519 · Cited by 225
Elucidation of the mechanism enabling tumor selective prodrug monotherapy.
Bosslet, K., Straub, R. H., Blumrich, M., Czech, J., Gerken, M., Sperker, B., Kroemer, H. K., Gesson, J., Koch, M. C., & Monneret, C. (1998) · PubMed · Cited by 225
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Tyrosine kinases as targets in cancer therapy – successes and failures
Traxler, P. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.215 · Cited by 226
Graphene Oxides Show Angiogenic Properties
Mukherjee, S., Sriram, P., Barui, A. K., Nethi, S. K., Veeriah, V., Chatterjee, S., Suresh, K. I., & Patra, C. R. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500155 · Cited by 220
Park, H.-J., Zhang, Y., Georgescu, S. P., Johnson, K. L., Kong, D., & Galper, J. B. (2006) · Stem Cell Reviews · doi:10.1007/s12015-006-0015-x · Cited by 220
The Id proteins and angiogenesis
Benezra, R., Rafii, S., & Lyden, D. (2001) · Oncogene · doi:10.1038/sj.onc.1205160 · Cited by 222
“Tumor growth induces an angiogenic switch which involves proliferation, migration, and stabiliza- Oncogene tion of new blood vessels (Folkman, 1995; Folkman and Shing, 1992; Hanahan, 1997; Hanahan and Folkman, 1996; Pepper, 1997; Risau, 1997, Bergers et al., 1999; Hanahan and Folkman, 1996).”
BackgroundAngiogenesis and Vasculogenesis Are Impaired in the Precocious-Aging klotho Mouse
Shimada, T., Takeshita, Y., Murohara, T., Sasaki, K.-I., Egami, K., Shintani, S., Katsuda, Y., Ikeda, H., Nabeshima, Y.-I., & Imaizumi, T. (2004) · Circulation · doi:10.1161/01.cir.0000139854.74847.99 · Cited by 215
Pediatric osteosarcoma: An updated review
Taran, R., Taran, S., & Malipatil, N. (2017) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.203513 · Cited by 220
MAP Kinases and Hypoxia in the Control of VEGF Expression
Berra, E., Pagès, G., & Pouysségur, J. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026506011458 · Cited by 223
Radisavljevic, Z., Avraham, H., & Avraham, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002448200 · Cited by 220
Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction
Conway, R. E., Petrovic, N., Li, Z., Heston, W., Wu, D., & Shapiro, L. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00084-06 · Cited by 222
Angiogenesis: basic pathophysiology and implications for disease
Felmeden, D. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00635-8 · Cited by 220
Dahlberg, S. E., Sandler, A. B., Brahmer, J. R., Schiller, J. H., & Johnson, D. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4482 · Cited by 223
On the Mechanism of Thrombin-induced Angiogenesis
Tsopanoglou, N. E., & Maragoudakis, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23969 · Cited by 219
Angiogenesis in brain tumors; pathobiological and clinical aspects
Wesseling, P., Ruiter, D. J., & Burger, P. C. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005746320099 · Cited by 218
Markowska, A. I., Jefferies, K. C., & Panjwani, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226423 · Cited by 218
Angiogenesis in chronic inflammatory liver disease
Medina, J., Arroyo, A. G., Sánchez-Madrid, F., & Moreno-Otero, R. (2004) · Hepatology · doi:10.1002/hep.20193 · Cited by 219
Metadata
- Authors
- Folkman, J.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Folkman, Judah
- Venue
- Nature Medicine
- Published
- 1995-01
- Volume
- 1
- Issue
- 1
- Pages
- 27-30
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2000000541
- Semantic Scholar
- 20a719a4d594caa54b1faa591d81eacb3f8d75c1
- Cited by
- 7,627
- References
- 62
- Citations by year
- 2026: 27 · 2025: 47 · 2024: 89 · 2023: 85 · 2022: 104 · 2021: 133 · 2020: 116 · 2019: 147 · 2018: 135 · 2017: 195 · 2016: 186 · 2015: 215 · 2014: 276 · 2013: 300 · 2012: 294
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, tumor angiogenesis, angiogenic switch, thrombospondin, angiostatin, carcinogenesis, metastasis, vascular disease, rheumatoid arthritis
- MeSH terms
- Animals, Arthritis, Rheumatoid, Eye, Humans, Lymphokines, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Peptide Fragments, Plasminogen, Psoriasis, Time Factors, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Angiostatins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.